AG˹ٷ

STOCK TITAN

[Form 4] Gevo, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Gevo (GEVO) Chief Business Officer Paul D. Bloom filed a Form 4 for a routine, pre-planned insider transaction dated 05 Aug 2025. Bloom sold 42,073 common shares at a weighted-average price of $1.2264 per share under a Rule 10b5-1 plan adopted 21 Nov 2024. The sale covered tax-withholding obligations arising from the vesting of a restricted-stock award.

After the sale Bloom still directly owns 1,000,683 shares and indirectly holds 22,047.57 shares in the company’s 401(k) plan. No derivative securities were transacted. The move trims roughly 4 % of his direct position and has no disclosed impact on company operations, strategy, or guidance.

Paul D. Bloom, Chief Business Officer di Gevo (GEVO), ha presentato un Modulo 4 per una transazione interna di routine e pre-pianificata datata 5 agosto 2025. Bloom ha venduto 42.073 azioni ordinarie a un prezzo medio ponderato di $1,2264 per azione, nell'ambito di un piano Rule 10b5-1 adottato il 21 novembre 2024. La vendita è stata effettuata per coprire gli obblighi fiscali derivanti dal vesting di un premio in azioni vincolate.

Dopo la vendita, Bloom detiene ancora direttamente 1.000.683 azioni e indirettamente 22.047,57 azioni nel piano 401(k) della società. Non sono stati effettuati scambi di titoli derivati. L'operazione riduce di circa il 4% la sua posizione diretta e non ha alcun impatto dichiarato sulle operazioni, sulla strategia o sulle previsioni aziendali.

Paul D. Bloom, Director Comercial de Gevo (GEVO), presentó un Formulario 4 para una transacción interna rutinaria y preplanificada con fecha 5 de agosto de 2025. Bloom vendió 42,073 acciones comunes a un precio promedio ponderado de $1.2264 por acción bajo un plan Rule 10b5-1 adoptado el 21 de noviembre de 2024. La venta cubrió obligaciones fiscales derivadas de la consolidación de una concesión de acciones restringidas.

Después de la venta, Bloom sigue poseyendo directamente 1,000,683 acciones y de forma indirecta 22,047.57 acciones en el plan 401(k) de la compañía. No se negociaron valores derivados. La operación reduce aproximadamente un 4% de su posición directa y no tiene impacto divulgado en las operaciones, estrategia o guía de la empresa.

Gevo(GEVO)� 최고사업책임�(CBO) Paul D. Bloom은 2025� 8� 5일자� 정기적이� 사전 계획� 내부� 거래� 위한 Form 4� 제출했습니다. Bloom은 2024� 11� 21� 채택� Rule 10b5-1 계획� 따라 주당 $1.2264� 가중평� 가격으� 42,073 보통�� 매도했습니다. 이번 매도� 제한주식 수여� 권리 확정� 따른 세금 원천징수 의무� 충당하기 위한 것이었습니다.

매도 � Bloom은 여전� 회사� 401(k) 플랜에서 22,047.57�� 간접 보유하고 있으�, 직접적으로는 1,000,683�� 보유하고 있습니다. 파생상품 거래� 없었습니�. 이번 거래� 그의 직접 보유 지분의 � 4%� 줄였으며, 회사� 운영, 전략 또는 가이던스에 공개� 영향은 없습니다.

Paul D. Bloom, directeur commercial de Gevo (GEVO), a déposé un formulaire 4 pour une transaction d’initié de routine et pré-planifiée datée du 5 août 2025. Bloom a vendu 42 073 actions ordinaires à un prix moyen pondéré de 1,2264 $ par action dans le cadre d’un plan Rule 10b5-1 adopté le 21 novembre 2024. La vente a servi à couvrir les obligations fiscales liées à l’acquisition d’une attribution d’actions restreintes.

Après la vente, Bloom détient toujours directement 1 000 683 actions et possède indirectement 22 047,57 actions dans le plan 401(k) de la société. Aucun titre dérivé n’a été négocié. Cette opération réduit d’environ 4 % sa position directe et n’a aucun impact déclaré sur les opérations, la stratégie ou les prévisions de l’entreprise.

Paul D. Bloom, Chief Business Officer von Gevo (GEVO), reichte am 5. August 2025 ein Formular 4 für eine routinemäßige, vorab geplante Insider-Transaktion ein. Bloom verkaufte 42.073 Stammaktien zu einem gewichteten Durchschnittspreis von 1,2264 $ pro Aktie im Rahmen eines Rule 10b5-1-Plans, der am 21. November 2024 angenommen wurde. Der Verkauf diente der Deckung von steuerlichen Verpflichtungen im Zusammenhang mit dem Erwerb einer Restricted-Stock-Auszeichnung.

Nach dem Verkauf besitzt Bloom weiterhin direkt 1.000.683 Aktien und hält indirekt 22.047,57 Aktien im 401(k)-Plan des Unternehmens. Es wurden keine Derivate gehandelt. Die Transaktion reduziert seine direkte Beteiligung um etwa 4 % und hat keine bekannten Auswirkungen auf die Geschäftstätigkeit, Strategie oder Prognosen des Unternehmens.

Positive
  • Sale executed under a pre-disclosed Rule 10b5-1 trading plan, supporting strong governance and transparency.
  • Insider retains over 1 million shares post-transaction, signalling continued alignment with shareholders.
Negative
  • Direct share ownership reduced by roughly 4 %, a modest but negative directional change in insider holdings.

Insights

TL;DR: Small, tax-driven insider sale; immaterial to float or valuation; neutral signal.

Bloom’s 42 k share sale represents about 4 % of his direct holdings and less than 0.02 % of Gevo’s ~250 M share float. Because the transaction was executed under a pre-arranged 10b5-1 plan and earmarked for withholding taxes, it does not suggest a shift in the insider’s long-term outlook. Remaining ownership above one million shares maintains alignment with shareholders. Overall impact on liquidity, earnings prospects, or valuation is negligible.

TL;DR: Properly disclosed 10b5-1 sale; governance compliance intact; negligible market impact.

The filing follows best-practice disclosure standards: Rule 10b5-1 plan identified, weighted-average pricing footnoted, and residual holdings stated. Such transparency reduces litigation risk and insider-trading concerns. The sale’s purpose—tax withholding on restricted stock—indicates routine compensation management rather than opportunistic disposal. No flags for governance or control issues arise.

Paul D. Bloom, Chief Business Officer di Gevo (GEVO), ha presentato un Modulo 4 per una transazione interna di routine e pre-pianificata datata 5 agosto 2025. Bloom ha venduto 42.073 azioni ordinarie a un prezzo medio ponderato di $1,2264 per azione, nell'ambito di un piano Rule 10b5-1 adottato il 21 novembre 2024. La vendita è stata effettuata per coprire gli obblighi fiscali derivanti dal vesting di un premio in azioni vincolate.

Dopo la vendita, Bloom detiene ancora direttamente 1.000.683 azioni e indirettamente 22.047,57 azioni nel piano 401(k) della società. Non sono stati effettuati scambi di titoli derivati. L'operazione riduce di circa il 4% la sua posizione diretta e non ha alcun impatto dichiarato sulle operazioni, sulla strategia o sulle previsioni aziendali.

Paul D. Bloom, Director Comercial de Gevo (GEVO), presentó un Formulario 4 para una transacción interna rutinaria y preplanificada con fecha 5 de agosto de 2025. Bloom vendió 42,073 acciones comunes a un precio promedio ponderado de $1.2264 por acción bajo un plan Rule 10b5-1 adoptado el 21 de noviembre de 2024. La venta cubrió obligaciones fiscales derivadas de la consolidación de una concesión de acciones restringidas.

Después de la venta, Bloom sigue poseyendo directamente 1,000,683 acciones y de forma indirecta 22,047.57 acciones en el plan 401(k) de la compañía. No se negociaron valores derivados. La operación reduce aproximadamente un 4% de su posición directa y no tiene impacto divulgado en las operaciones, estrategia o guía de la empresa.

Gevo(GEVO)� 최고사업책임�(CBO) Paul D. Bloom은 2025� 8� 5일자� 정기적이� 사전 계획� 내부� 거래� 위한 Form 4� 제출했습니다. Bloom은 2024� 11� 21� 채택� Rule 10b5-1 계획� 따라 주당 $1.2264� 가중평� 가격으� 42,073 보통�� 매도했습니다. 이번 매도� 제한주식 수여� 권리 확정� 따른 세금 원천징수 의무� 충당하기 위한 것이었습니다.

매도 � Bloom은 여전� 회사� 401(k) 플랜에서 22,047.57�� 간접 보유하고 있으�, 직접적으로는 1,000,683�� 보유하고 있습니다. 파생상품 거래� 없었습니�. 이번 거래� 그의 직접 보유 지분의 � 4%� 줄였으며, 회사� 운영, 전략 또는 가이던스에 공개� 영향은 없습니다.

Paul D. Bloom, directeur commercial de Gevo (GEVO), a déposé un formulaire 4 pour une transaction d’initié de routine et pré-planifiée datée du 5 août 2025. Bloom a vendu 42 073 actions ordinaires à un prix moyen pondéré de 1,2264 $ par action dans le cadre d’un plan Rule 10b5-1 adopté le 21 novembre 2024. La vente a servi à couvrir les obligations fiscales liées à l’acquisition d’une attribution d’actions restreintes.

Après la vente, Bloom détient toujours directement 1 000 683 actions et possède indirectement 22 047,57 actions dans le plan 401(k) de la société. Aucun titre dérivé n’a été négocié. Cette opération réduit d’environ 4 % sa position directe et n’a aucun impact déclaré sur les opérations, la stratégie ou les prévisions de l’entreprise.

Paul D. Bloom, Chief Business Officer von Gevo (GEVO), reichte am 5. August 2025 ein Formular 4 für eine routinemäßige, vorab geplante Insider-Transaktion ein. Bloom verkaufte 42.073 Stammaktien zu einem gewichteten Durchschnittspreis von 1,2264 $ pro Aktie im Rahmen eines Rule 10b5-1-Plans, der am 21. November 2024 angenommen wurde. Der Verkauf diente der Deckung von steuerlichen Verpflichtungen im Zusammenhang mit dem Erwerb einer Restricted-Stock-Auszeichnung.

Nach dem Verkauf besitzt Bloom weiterhin direkt 1.000.683 Aktien und hält indirekt 22.047,57 Aktien im 401(k)-Plan des Unternehmens. Es wurden keine Derivate gehandelt. Die Transaktion reduziert seine direkte Beteiligung um etwa 4 % und hat keine bekannten Auswirkungen auf die Geschäftstätigkeit, Strategie oder Prognosen des Unternehmens.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bloom Paul D

(Last) (First) (Middle)
C/O GEVO, INC. 345 INVERNESS DRIVE SOUTH
BUILDING C, SUITE 310

(Street)
ENGLEWOOD CO 80112

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Gevo, Inc. [ GEVO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Business Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/05/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/05/2025 S(1) 42,073 D $1.2264(2) 1,000,683 D
Common Stock 22,047.57 I By 401(k) Plan
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares sold by the Reporting Person to cover tax withholding obligations upon vesting of a restricted stock award. The reported sales were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 21, 2024.
2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.21 to $1.28 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ E. Cabell Massey, Attorney-in-Fact 08/06/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many GEVO shares did Paul D. Bloom sell?

He sold 42,073 common shares on 05 Aug 2025.

At what price were the GEVO shares sold?

The weighted-average sale price was $1.2264 per share (range $1.21�$1.28).

Why did the insider sell the shares?

The shares were sold solely to cover tax-withholding obligations upon vesting of a restricted-stock award.

How many GEVO shares does Bloom hold after the sale?

He holds 1,000,683 shares directly and 22,047.57 shares indirectly via the 401(k) plan.

What is a Rule 10b5-1 trading plan?

It is a pre-arranged schedule for buying or selling shares that provides an affirmative defense against insider-trading claims.
Gevo Inc

NASDAQ:GEVO

GEVO Rankings

GEVO Latest News

GEVO Latest SEC Filings

GEVO Stock Data

280.29M
228.50M
4.34%
24.27%
16.82%
Specialty Chemicals
Industrial Organic Chemicals
United States
ENGLEWOOD